• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过原子力显微镜研究表面粗糙度对乳糖载体上昔萘酸沙美特罗粘附力分布的影响

Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy.

作者信息

Islam Nazrul, Stewart Peter, Larson Ian, Hartley Patrick

机构信息

Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia.

出版信息

J Pharm Sci. 2005 Jul;94(7):1500-11. doi: 10.1002/jps.20381.

DOI:10.1002/jps.20381
PMID:15924347
Abstract

Adhesion force distributions of silica spheres (5 and 20 microm) and salmeterol xinafoate (4 microm) particles with inhalation grade lactose surfaces and spin coated lactose films were determined by atomic force microscopy (AFM) to investigate the influence of surface roughness on the force distributions. The roughness of lactose particles and films was determined by both AFM and confocal microscopy (CM); the lactose particles showed RMS R(q) values between 0.93 and 2.2 microm. The adhesion force distributions for silica and SX probes were significantly different for the different lactose carriers and broad, e.g., the adhesion force distribution between a 5 microm silica sphere and lactose particles ranged from 5 to 105 nN. This contrasted with distributions on smooth spin coated lactose films (RMS R(q) of 0.28 nm) which were not significantly different and were narrow, e.g., the adhesion force distribution between a 5 microm silica sphere and spin coated lactose films was between 42 and 68 nN. In addition, no significant difference in adhesion force distribution occurred with silica probe size on the lactose carrier surface. The use of X-ray photoelectron spectroscopic analysis confirmed that the lactose surfaces were free of impurities that might contribute to variation in adhesion. Although the almost atomically flat films showed some adhesion variability, the surface roughness of the lactose particles was a major contributing factor to the broad distributions seen in this study.

摘要

通过原子力显微镜(AFM)测定了二氧化硅球体(5微米和20微米)以及昔萘酸沙美特罗(4微米)颗粒与吸入级乳糖表面和旋涂乳糖膜之间的粘附力分布,以研究表面粗糙度对力分布的影响。乳糖颗粒和膜的粗糙度通过AFM和共聚焦显微镜(CM)测定;乳糖颗粒的均方根粗糙度R(q)值在0.93至2.2微米之间。对于不同的乳糖载体,二氧化硅和昔萘酸沙美特罗(SX)探针的粘附力分布存在显著差异且范围较宽,例如,5微米二氧化硅球体与乳糖颗粒之间的粘附力分布范围为5至105纳牛。这与光滑旋涂乳糖膜(均方根粗糙度R(q)为0.28纳米)上的分布形成对比,后者差异不显著且范围较窄,例如,5微米二氧化硅球体与旋涂乳糖膜之间的粘附力分布在42至68纳牛之间。此外,在乳糖载体表面,二氧化硅探针尺寸对粘附力分布没有显著影响。X射线光电子能谱分析的结果证实,乳糖表面不存在可能导致粘附力变化的杂质。尽管几乎原子级平整的膜表现出一定的粘附力变异性,但乳糖颗粒的表面粗糙度是本研究中观察到的宽分布的主要促成因素。

相似文献

1
Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy.通过原子力显微镜研究表面粗糙度对乳糖载体上昔萘酸沙美特罗粘附力分布的影响
J Pharm Sci. 2005 Jul;94(7):1500-11. doi: 10.1002/jps.20381.
2
Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.吸入用昔萘酸沙美特罗粉末混合物的团聚强度和分散性。
Pharm Res. 2006 Nov;23(11):2556-65. doi: 10.1007/s11095-006-9082-6. Epub 2006 Sep 14.
3
Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.昔萘酸沙美特罗颗粒在吸入用糖基混合物中的黏附与再分布。
Int J Pharm. 2007 Jun 7;337(1-2):229-38. doi: 10.1016/j.ijpharm.2007.01.007. Epub 2007 Jan 14.
4
Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures.载体大小对昔萘酸沙美特罗从交互式混合物中分散的影响。
J Pharm Sci. 2004 Apr;93(4):1030-8. doi: 10.1002/jps.10583.
5
Role of agglomeration in the dispersion of salmeterol xinafoate from mixtures for inhalation with differing drug to fine lactose ratios.凝聚在不同药物与乳糖比例的吸入用混合物中昔萘酸沙美特罗分散方面的作用。
J Pharm Sci. 2008 Aug;97(8):3140-52. doi: 10.1002/jps.21228.
6
Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?沉淀法对乳糖表面的修饰:药物细粉乳糖比例是否是改善昔萘酸沙美特罗从乳糖相互作用混合物中分散性的关键?
Pharm Res. 2004 Mar;21(3):492-9. doi: 10.1023/B:PHAM.0000019304.91412.18.
7
Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.赤藓糖醇与乳糖一水合物作为吸入载体的比较研究:原子力显微镜及体外相关性
Eur J Pharm Sci. 2006 Feb;27(2-3):243-51. doi: 10.1016/j.ejps.2005.10.005. Epub 2005 Dec 5.
8
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.用于吸入丙酸氟替卡松和昔萘酸沙美特罗微晶的干粉制剂。
J Pharm Sci. 2009 Feb;98(2):503-15. doi: 10.1002/jps.21450.
9
Lactose composite carriers for respiratory delivery.用于呼吸道给药的乳糖复合载体。
Pharm Res. 2009 Apr;26(4):802-10. doi: 10.1007/s11095-008-9779-9. Epub 2008 Nov 18.
10
Characterisation of adhesional properties of lactose carriers using atomic force microscopy.
J Pharm Biomed Anal. 2001 Jun;25(3-4):559-67. doi: 10.1016/s0731-7085(00)00523-9.

引用本文的文献

1
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation.脂质聚合物杂化纳米粒子对抗肺癌及其作为吸入制剂的应用。
Nanomedicine (Lond). 2024;19(25):2113-2133. doi: 10.1080/17435889.2024.2387530. Epub 2024 Aug 15.
2
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.干粉吸入器设计和颗粒技术在增强肺部药物沉积中的作用:挑战与未来策略。
Daru. 2024 Dec;32(2):761-779. doi: 10.1007/s40199-024-00520-3. Epub 2024 Jun 11.
3
Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections.
用于治疗下呼吸道感染的吸入式载抗生素聚合物纳米颗粒。
Nanoscale Adv. 2021 May 17;3(14):4005-4018. doi: 10.1039/d1na00205h. eCollection 2021 Jul 13.
4
Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.装置设计与剂型对多剂量干粉吸入器体外可比性的影响
AAPS J. 2015 Sep;17(5):1105-16. doi: 10.1208/s12248-015-9775-z. Epub 2015 May 9.
5
Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.粒状乳糖作为干粉吸入剂制剂载体的评价1:颗粒大小的影响。
AAPS PharmSciTech. 2014 Dec;15(6):1417-28. doi: 10.1208/s12249-014-0166-z. Epub 2014 Jun 25.
6
Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.聚己内酯微球粒径对硫酸沙丁胺醇干粉吸入剂制剂分散效果的研究。
Pharm Res. 2012 Sep;29(9):2445-55. doi: 10.1007/s11095-012-0772-y. Epub 2012 May 15.
7
The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems.不同制剂成分对载药型干粉吸入器系统中气溶胶荷电的影响。
Pharm Res. 2010 Jul;27(7):1325-36. doi: 10.1007/s11095-010-0115-9. Epub 2010 Mar 31.
8
The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations.粉末吸入剂配方中,细粉在改变流化和分散机制方面的作用。
Pharm Res. 2008 Jul;25(7):1631-40. doi: 10.1007/s11095-008-9538-y. Epub 2008 Feb 1.